• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

2.900 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.900
Bid (Size) 2.650 (100)
Ask (Size) 3.000 (300)
Prev. Close 2.900
Today's Range 2.900 - 2.900
52wk Range 2.501 - 12.00
Shares Outstanding 19,474,303
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
October 21, 2026
Growing investment in next-generation CNS cancer therapies is driving research into targeted drugs, immunotherapy and new approaches to treating aggressive brain tumors. 
From FN Media
Via GlobeNewswire
News headline image
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
October 21, 2026
EQNX::TICKER_START (NASDAQ:NTHI),(NASDAQ:NBIX),(NASDAQ:ACAD),(NASDAQ:AVXL),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia

Performance

52-Week Range 75.8% below 52-week high
2.900
2.5052W Low 12.0052W High
1 Week 2.0% below 1-week high
2.661W Low 2.961W High

NeOnc Technologies Holdings, Inc. - Common Stock (NTHI) traded between $2.50 and $12.00 over the past 52 weeks and last traded at $2.90, 75.8% below its 52-week high. Over the past week it ranged between $2.66 and $2.96.

Past 12 Months
+5.5%
-12.9%
-21.0%
-41.4%
-67.3%
-69.4%
1W +$0.15
1M -$0.43
3M -$0.77
6M -$2.05
YTD -$5.98
1Y -$6.57

NTHI was -69.4% over the past year, -41.4% over six months, -67.3% year to date, +5.5% in the last week.

12 Months vs Market
NTHI
-69.4%
DIA
+12.5%
SPY
+15.2%
QQQ
+18.6%
IWM
+11.9%

Over the past 12 months NTHI returned -69.4% versus DIA (Dow) +12.5%, SPY (S&P 500) +15.2%, QQQ (Nasdaq 100) +18.6% and IWM (Russell 2000) +11.9%.

Volume & Liquidity
1W
106.6K
1M
147.6K
3M
196.7K
6M
148.9K
YTD
112.8K
1Y
103.4K

NTHI's 3-month average daily volume is 196.7K.

More News

Read More
News headline image
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
October 21, 2026
Via Newsfile
News headline image
NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
October 21, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus
October 16, 2026
Via Newsfile
News headline image
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
October 16, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026
October 15, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
October 14, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
September 28, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
September 17, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results
September 16, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors
September 09, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA
August 15, 2026
From New to The Street
Via ACCESS Newswire
News headline image
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26
August 13, 2026
Via Newsfile
News headline image
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
August 12, 2026
Via Newsfile
News headline image
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
August 12, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence
August 11, 2026
Via Newsfile
News headline image
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
August 10, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
August 10, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
July 27, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
July 15, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
June 23, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
June 22, 2026
Via Newsfile
News headline image
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
June 16, 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates
June 15, 2026
Via Newsfile

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?
Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.
What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?
NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?
The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market
What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?
The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 2.900
When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?
The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 10/21/26 04:00 PM ET
What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?
The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 56.48M
How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?
NeOnc Technologies Holdings, Inc. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap